I suspect they'll try and release earnings and/or any other skeleton they have in the closet in order to "capitalize" on what's already happened today and get this stuff behind them. Interestingly, Paine Webber reiterated a strong buy this a.m. Now in addition to the FDA they're gonna have some analysts pissed off at them too. Nevertheless, I think this is a good company that has not been a particularly good investment over the last few months. But look at the chart. It's done this before and come back. Suspect this time will be no different.